| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10918901 | Radiotherapy and Oncology | 2013 | 7 Pages |
Abstract
Despite dose escalation, the use of FMIGRT in radical radiotherapy for prostate cancer significantly reduces the incidence of gastrointestinal toxicity and the duration of late genitourinary toxicity when compared to conventional non-FMIGRT techniques.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
David Kok, Suki Gill, Mathias Bressel, Keelan Byrne, Tomas Kron, Chris Fox, Gillian Duchesne, Keen Hun Tai, Farshad Foroudi,